Tasly Pharmaceutical Group Co., Ltd (SHSE: 600535)
Health Care · Pharmaceuticals · CN
CN¥14.20
+1.43% today · -11.7% 1Y
Tasly Pharmaceutical Group Co., Ltd (SHSE: 600535) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $3.17B and employs 10,563 people.
Over the last twelve months the share price has lost 11.7%, trading between 12.90 and 16.24.
Tweenvest scores Tasly Pharmaceutical Group Co., Ltd across four factors: quality 75/100, value 68/100, growth 0/100, dividend 77/100. Its strongest factor is dividend.
600535 price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $3.17B
- Revenue (TTM)
- $1.20B
- P/E
- 17.37
- EPS
- 0.82
- Dividend yield
- 2.18%
- Beta (5Y)
- 0.21
- 52-week high
- CN¥16.24
- 52-week low
- CN¥12.90
- Avg volume (3M)
- —
- Shares outstanding
- 1.49B
- Employees
- 10,563
- Next earnings
- —
About Tasly Pharmaceutical Group Co., Ltd
Tasly Pharmaceutical Group Co., Ltd., a company founded in 1994 and based in Tianjin, China, is actively engaged in the biological medicine, health, and medical service industries within China. Its extensive product catalog encompasses a wide range of goods, including both traditional herbal and modern chemical medicines, alongside various health supplements. The firm also supplies key pharmaceutical ingredients (APIs), concentrated herbal granules, herbal extracts, and a diverse selection of tea products. Beyond its core pharmaceutical offerings, Tasly manufactures cosmetic lines featuring items such as moisturizing lotions, facial creams, eye creams, and cleansing foams. Additionally, its consumer goods division provides daily hygiene essentials like sanitary and carefree pads, in addition to specialized soaps made with honey-propolis and pollen. The company further distributes medical equipment, including different types of massage devices like tappers and cushions, as well as circulation-enhancing machines. Tasly's market presence extends globally, with significant exports directed to the United States, Russia, and numerous countries across Europe, Africa, and other parts of Asia.
- ISIN
- CNE000001C81
- Founded
- 1994
- Listed since
- Aug 23, 2002
- Exchange
- Shanghai Stock Exchange
- Currency
- CNY
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Jiangsu Nhwa Pharmaceutical Co., LTDSZSE: 002262 | $3.30B | CN¥21.74 | -4.36% |
| China Medical System Holdings LimitedSEHK: 867 | $3.27B | HK$10.54 | +0.96% |
| Guangdong Zhongsheng Pharmaceutical Co., Ltd.SZSE: 002317 | $3.23B | CN¥25.49 | +6.08% |
| Tarsus Pharmaceuticals, Inc.NasdaqGS: TARS | $3.21B | $75.77 | +3.57% |
| Hybio Pharmaceutical Co., Ltd.SZSE: 300199 | $3.13B | CN¥23.71 | -0.88% |
| Evopoint Biosciences Co., Ltd.SHSE: 688837 | $3.07B | CN¥47.25 | -4.35% |
| Jilin Aodong Pharmaceutical Group Co., Ltd.SZSE: 000623 | $3.07B | CN¥17.53 | +0.69% |
| Betta Pharmaceuticals Co., Ltd.SZSE: 300558 | $3.04B | CN¥48.43 | -4.06% |
Figures last refreshed Oct 11, 2026.